Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A feedback dissemination meeting on the just concluded Nairobi newborn study took place on Monday 30th January and was attended by 75 delegates. Discussions were on: routine newborn care in newborn units, infrastructure and services available in health facilities, accessibility of drugs, newborn care in the maternity wards, material and human resource capacity, utilization of inpatient newborn services; and the quality of existing services.

CTMGH logo for News

Representatives from 32 health facilities across Nairobi City County from public, private and faith-based hospitals who participated in the study attended. Partners in the study including the Ministry of Health, the Nursing Council of Kenya, the University of Nairobi, UNICEF, the University of Nairobi and Save the Children were also present.

The ongoing study is part of a larger study referred to as Health Services that Deliver for Newborns (HSD-N) and has five phases, which are: exploring the quality of and need for inpatient neonatal care in Nairobi City County; exploring the context of neonatal nursing, how nurses manage the pressures of working in a newborn unit; task analysis, describing tasks missed care, quantifying tasks done and those not done; understanding what influences the ability of nurses to provide quality inpatient care; documenting the roles and perceptions of mothers of hospitalized sick newborns. The last phase of the study is due for completion in the first quarter of 2018.

Similar stories

Modelling the Cost-Effectiveness of COVID-19 Vaccination Strategies in Kenya

The KEMRI-Wellcome Trust Research Programme today released the results of its latest modelling on COVID-19 vaccine scale-up within the country. The analysis found that the country’s COVID-19 vaccination campaign can achieve greater value for money if it focuses on the elderly, rather than a strategy that pursues scaling up vaccines to the whole population.

Emelda Okiro awarded Wellcome Senior Research Fellowship

Dr Emelda Okiro has been awarded the prestigious Wellcome Senior Research Fellowship. Emelda’s fellowship is the first African Senior Research Fellowship awarded in the KEMRI-Wellcome Research Programme and among the less than five SRFs awarded to researchers in Africa.

Large African and South Asian research network finds half of deaths among children admitted to hospital happens after discharge

Young children in sub-Saharan Africa and South Asia who become sick or malnourished continue to have a high risk of death in the six months after being hospitalized, according to findings by researchers in the Childhood Acute Illness & Nutrition (CHAIN) Network. Appearing in The Lancet Global Health, the study of 3,101 acutely ill children at nine hospitals in six countries across sub-Saharan Africa and South Asia found that 48% of the 350 deaths recorded occurred within six months after discharge from hospital.

Community and Public Engagement at KWTRP

Monitoring and Evaluation helps us keep track of our public engagement activities and outcomes. KEMRI -Wellcome Trust recently completed a report detailing our experiences and learning.

Potentially life-saving treatment is safe to use for babies with neonatal sepsis

Results from a clinical trial completed in Kenya have determined that a safe dose of the antibiotic, fosfomycin, can be used to treat babies with neonatal sepsis. This is a significant development, as there are very few antibiotics specifically licensed to treat multidrug-resistant infections in babies. This research was lead by Dr Christina Obiero and Professor Jay Berkley.

Cross-species vaccination by Professor George Warimwe

Royal Society 2021 Africa Prize lecture from Professor George Warimwe. More than 70% of emerging infectious diseases (including viruses) are zoonotic, meaning they are acquired from animals, with some causing serious illness and death in humans as well as the animal host. But, what if we could immunise both humans and animals with the same vaccine?